Brain abnormalities in Sjogren syndrome with recurrent CNS manifestations: association with neuromyelitis optica.

Brain abnormalities in Sjogren syndrome with recurrent CNS manifestations: association with neuromyelitis optica.

BACKGROUND AND OBJECTIVES: Optic neuritis or longitudinally extensive myelitis in Sjogren syndrome (SS) suggests a neuromyelitis optica spectrum disorder (NMOSD). However, brain abnormalities of SS remain to be elucidated for the association with neuromyelitis optica (NMO). METHODS: Twelve primary...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Min, J, Kim, H, Kim, B, Lee, K, Sunwoo, I, Kim, S, Park, MS, Waters, P, Vincent, A, Sung, J
Fformat:	Journal article
Iaith:	English
Cyhoeddwyd:	2009

Eitemau Tebyg

Sjögren's syndrome myelopathy: Spinal cord involvement in Sjögren's syndrome might be a manifestation of neuromyelitis optica
gan: Kim, S, et al.
Cyhoeddwyd: (2009)

Sjogren's syndrome myelopathy: spinal cord involvement in Sjogren's syndrome might be a manifestation of neuromyelitis optica.
gan: Kim, S, et al.
Cyhoeddwyd: (2009)

Symptomatic brain involvement as the initial manifestation of neuromyelitis optica.
gan: Min, J, et al.
Cyhoeddwyd: (2013)

Utility of aquaporin-4 antibody assay in patients with neuromyelitis optica spectrum disorders.
gan: Kim, S, et al.
Cyhoeddwyd: (2013)

Anti-aquaporin 4 antibody-positivity of Korean patients with neuromyelitis optica spectrum disorders
gan: Min, J, et al.
Cyhoeddwyd: (2010)

Cell-based assay for anti-AQP4 antibody in Korean patients with neuromyelitis optica
gan: Kim, B, et al.
Cyhoeddwyd: (2010)

Cerebrospinal fluid/serum gradient of IgG is associated with disability at acute attacks of neuromyelitis optica.
gan: Kim, S, et al.
Cyhoeddwyd: (2011)

Distinct features of B cell receptors in neuromyelitis optica spectrum disorder among CNS inflammatory demyelinating diseases
gan: Hyo Jae Kim, et al.
Cyhoeddwyd: (2023-10-01)

Cytotoxic edema in a patient with neuromyelitis optica: This may be suggestive of various pathogenic roles of NMO-IgG
gan: Min, J, et al.
Cyhoeddwyd: (2010)

Influence of pregnancy on neuromyelitis optica spectrum disorder.
gan: Kim, W, et al.
Cyhoeddwyd: (2012)

Gender effect on neuromyelitis optica spectrum disorder with aquaporin4-immunoglobulin G
gan: Kim, S-M, et al.
Cyhoeddwyd: (2016)

Gender effect on neuromyelitis optica spectrum disorder with aquaporin4-immunoglobulin G
gan: Kim, S-M, et al.
Cyhoeddwyd: (2017)

Low levels of vitamin D in neuromyelitis optica spectrum disorder: association with disease disability
gan: Min, J, et al.
Cyhoeddwyd: (2014)

Differential diagnosis of neuromyelitis optica spectrum disorders
gan: Sung-Min Kim, et al.
Cyhoeddwyd: (2017-07-01)

Higher frequency of brain abnormalities in neuromyelitis optica spectrum disorder patients without primary Sjögren′s syndrome
gan: Li-na Gu, et al.
Cyhoeddwyd: (2016-01-01)

Reduced serum uric acid levels in neuromyelitis optica: serum uric acid levels are reduced during relapses in NMO.
gan: Min, J, et al.
Cyhoeddwyd: (2012)

Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice.
gan: Saadoun, S, et al.
Cyhoeddwyd: (2010)

Severe dystonia as the first manifestation of neuromyelitis optica
gan: Yára Dadalti Fragoso, et al.
Cyhoeddwyd: (2012-09-01)

Genetic factors for susceptibility to and manifestations of neuromyelitis optica
gan: Takuya Matsushita, et al.
Cyhoeddwyd: (2020-11-01)

Intractable nausea and vomiting as presenting manifestation of neuromyelitis optica
gan: Sujit A Jagtap, et al.
Cyhoeddwyd: (2013-01-01)

A Rare Case of Neuromyelitis Optica Spectrum Disorder in Patient with Sjogren’s Syndrome
gan: Supat Thongpooswan, et al.
Cyhoeddwyd: (2014-01-01)

Racial differences in neuromyelitis optica spectrum disorder
gan: Kim, S, et al.
Cyhoeddwyd: (2018)

Neuro-ophthalmic manifestation of neuromyelitis optica spectrum disorders
gan: Xiao-jun ZHANG, et al.
Cyhoeddwyd: (2014-10-01)

Antibodies to aquaporin-1 are not present in neuromyelitis optica
gan: Waters, P, et al.
Cyhoeddwyd: (2015)

Complement activation in patients with neuromyelitis optica
gan: Nytrova, P, et al.
Cyhoeddwyd: (2014)

Complement activation in patients with neuromyelitis optica.
gan: Nytrova, P, et al.
Cyhoeddwyd: (2014)

Neuromyelitis Optica
gan: Goyal V, et al.
Cyhoeddwyd: (2009-10-01)

Neuromyelitis optica
gan: Jacob Anu, et al.
Cyhoeddwyd: (2007-01-01)

Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica.
gan: Jarius, S, et al.
Cyhoeddwyd: (2008)

Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
gan: Collongues, N, et al.
Cyhoeddwyd: (2013)

Deep Learning-Based Method to Differentiate Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis
gan: Hyunjin Kim, et al.
Cyhoeddwyd: (2020-11-01)

Neuromyelitis optica spectrum disorders as initial presentation of Sjögren's syndrome: A case report
gan: Carlos Alva Díaz, et al.
Cyhoeddwyd: (2016-03-01)

The borderland of neuromyelitis optica.
gan: Matthews, L, et al.
Cyhoeddwyd: (2009)

Symptomatic, radiological and pathological involvement of the hypothalamus in neuromyelitis optica.
gan: Viegas, S, et al.
Cyhoeddwyd: (2009)

Cortical blindness: An unusual manifestation of neuromyelitis optica spectrum disorder
gan: Ram Bhupal Reddy Nagireddy, et al.
Cyhoeddwyd: (2022-01-01)

Systemic manifestations and pathogenesis exploration of neuromyelitis optica spectrum disorders
gan: Hong JIANG, et al.
Cyhoeddwyd: (2014-09-01)

TREATMENT OF NEUROMYELITIS OPTICA WITH AZATHIOPRINE
gan: Elsone, L, et al.
Cyhoeddwyd: (2012)

Factors associated with the time to next attack in neuromyelitis optica: accelerated failure time models with random effects.
gan: Sung-Min Kim, et al.
Cyhoeddwyd: (2013-01-01)

The impact of neuromyelitis optica spectrum disorder on pregnancy outcome
gan: Nour, M, et al.
Cyhoeddwyd: (2014)

Low levels of vitamin D in neuromyelitis optica spectrum disorder: association with disease disability.
gan: Ju-Hong Min, et al.
Cyhoeddwyd: (2014-01-01)